Trends in all-cause mortality and inpatient and outpatient visits for ambulatory care sensitive conditions during the first year of the COVID-19 pandemic: A population-based study.
Journal
Journal of hospital medicine
ISSN: 1553-5606
Titre abrégé: J Hosp Med
Pays: United States
ID NLM: 101271025
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
28
06
2022
received:
01
04
2022
accepted:
28
06
2022
pubmed:
6
8
2022
medline:
17
9
2022
entrez:
5
8
2022
Statut:
ppublish
Résumé
The impact of the COVID-19 pandemic on the management of ambulatory care sensitive conditions (ACSCs) remains unknown. To compare observed and expected (projected based on previous years) trends in all-cause mortality and healthcare use for ACSCs in the first year of the pandemic (March 2020 to March 2021). We conducted a population-based study using provincial health administrative data on general adul population (Ontario, Canada). Monthly all-cause mortality, and hospitalizations, emergency department (ED) and outpatient visit rates (per 100,000 people at-risk) for seven combined ACSCs (asthma, chronic obstructive pulmonary disease, angina, congestive heart failure, hypertension, diabetes, and epilepsy) during the first year were compared with similar periods in previous years (2016-2019) by fitting monthly time series autoregressive integrated moving-average models. Compared to previous years, all-cause mortality rates increased at the beginning of the pandemic (observed rate in March to May 2020 of 79.98 vs. projected of 71.24 [66.35-76.50]) and then returned to expected in June 2020-except among immigrants and people with mental health conditions where they remained elevated. Hospitalization and ED visit rates for ACSCs remained lower than projected throughout the first year: observed hospitalization rate of 37.29 versus projected of 52.07 (47.84-56.68); observed ED visit rate of 92.55 versus projected of 134.72 (124.89-145.33). ACSC outpatient visit rates decreased initially (observed rate of 4299.57 vs. projected of 5060.23 [4712.64-5433.46]) and then returned to expected in June 2020.
Sections du résumé
BACKGROUND
The impact of the COVID-19 pandemic on the management of ambulatory care sensitive conditions (ACSCs) remains unknown.
OBJECTIVES
To compare observed and expected (projected based on previous years) trends in all-cause mortality and healthcare use for ACSCs in the first year of the pandemic (March 2020 to March 2021).
DESIGN, SETTING AND PARTICIPANTS
We conducted a population-based study using provincial health administrative data on general adul population (Ontario, Canada).
OUTCOMES AND MEASURES
Monthly all-cause mortality, and hospitalizations, emergency department (ED) and outpatient visit rates (per 100,000 people at-risk) for seven combined ACSCs (asthma, chronic obstructive pulmonary disease, angina, congestive heart failure, hypertension, diabetes, and epilepsy) during the first year were compared with similar periods in previous years (2016-2019) by fitting monthly time series autoregressive integrated moving-average models.
RESULTS
Compared to previous years, all-cause mortality rates increased at the beginning of the pandemic (observed rate in March to May 2020 of 79.98 vs. projected of 71.24 [66.35-76.50]) and then returned to expected in June 2020-except among immigrants and people with mental health conditions where they remained elevated. Hospitalization and ED visit rates for ACSCs remained lower than projected throughout the first year: observed hospitalization rate of 37.29 versus projected of 52.07 (47.84-56.68); observed ED visit rate of 92.55 versus projected of 134.72 (124.89-145.33). ACSC outpatient visit rates decreased initially (observed rate of 4299.57 vs. projected of 5060.23 [4712.64-5433.46]) and then returned to expected in June 2020.
Identifiants
pubmed: 35929531
doi: 10.1002/jhm.12920
pmc: PMC9539068
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
726-737Subventions
Organisme : Ontario Health Data Platform (OHDP)
Organisme : Ottawa Hospital Academic Medical Organization (TOHAMO)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 Society of Hospital Medicine.
Références
Can J Public Health. 2001 Mar-Apr;92(2):155-9
pubmed: 11338156
Emerg Med Australas. 2021 Apr;33(2):316-323
pubmed: 33070468
J Formos Med Assoc. 2009 May;108(5):386-94
pubmed: 19443292
Am J Clin Oncol. 2020 Jun;43(6):452-455
pubmed: 32304435
Risk Manag Healthc Policy. 2021 Feb 15;14:575-584
pubmed: 33623448
BMJ Open. 2022 May 9;12(5):e056868
pubmed: 35534055
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2774-2776.e1
pubmed: 32522565
PLoS One. 2021 Jun 1;16(6):e0252441
pubmed: 34061888
Can J Cardiol. 2020 Jul;36(7):1148-1151
pubmed: 32405146
Clin Cardiol. 2020 Oct;43(10):1142-1149
pubmed: 32691901
Acta Paediatr. 2020 Oct;109(10):2144-2146
pubmed: 32575149
JAMA Netw Open. 2021 Oct 1;4(10):e2129973
pubmed: 34705016
Can J Psychiatry. 2021 Sep;66(9):815-826
pubmed: 33464115
Ann Am Thorac Soc. 2021 Apr;18(4):717-719
pubmed: 33272107
Am J Public Health. 1997 May;87(5):811-6
pubmed: 9184511
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
JAMA. 2020 Jul 28;324(4):321-323
pubmed: 32556122
PLoS One. 2020 Nov 20;15(11):e0242653
pubmed: 33216804
Lancet. 2021 Feb 20;397(10275):650-652
pubmed: 33539727
BMJ Open Diabetes Res Care. 2020 Jul;8(1):
pubmed: 32690631
J Card Fail. 2020 Jun;26(6):462-463
pubmed: 32405232
J Hosp Med. 2022 Sep;17(9):726-737
pubmed: 35929531
JAMA Psychiatry. 2021 Nov 1;78(11):1208-1217
pubmed: 34313711
Med J Islam Repub Iran. 2020 Jul 15;34:80
pubmed: 33306040
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
BMC Med Inform Decis Mak. 2016 Oct 21;16(1):135
pubmed: 27769227